- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Allergan Medical
Total 60050 results
-
AllerganCompleted
-
AllerganTerminated
-
AllerganCompletedAcne VulgarisUnited States
-
AllerganCompletedIdiopathic Eyelash HypotrichosisRussian Federation, Sweden, United States, United Kingdom
-
AllerganCompletedGlabellar Lines | Frown Lines | Crow's Feet Lines | Upper Facial RhytidesJapan
-
AllerganCompletedMacular Edema | Retinal Vein OcclusionDenmark, Norway, Sweden
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
AllerganCompletedDiabetic Macular EdemaSpain, South Africa, Canada, Czech Republic, Germany, Israel, Australia, Portugal, United States, Philippines
-
AllerganCompletedHealthy VolunteersUnited States
-
AllerganCompletedCataract | Dry Eye SyndromesChina
-
AllerganCompletedAlopecia | BaldnessUnited States, Germany
-
AllerganCompletedUrinary Bladder, OveractiveFrance, United States, Netherlands
-
AllerganWithdrawn
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleKorea, Republic of
-
AllerganCompletedConjunctivitis, AllergicUnited States
-
AllerganCompletedMigraine DisordersUnited Kingdom, United States, Switzerland, Canada, Germany, Croatia
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleUnited States
-
AllerganCompletedRhegmatogenous Macula-off Retinal DetachmentUnited Kingdom, Korea, Republic of, Israel, India, United States, Philippines
-
AllerganCompletedRetinitis PigmentosaFrance, United States, Germany, Portugal
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Belgium, Russian Federation, Czech Republic, Germany, United States
-
AllerganWithdrawn
-
AllerganCompleted
-
AllerganTerminatedGlaucoma, Angle-ClosureThailand
-
AllerganCompletedObesity | Overactive Bladder | IncontinenceUnited States
-
AllerganCompletedChoroidal Neovascularization | Age-Related MaculopathyUnited States, Australia, Philippines
-
AllerganCompleted
-
AllerganCompleted
-
AllerganCompletedAnti-biotic ResistanceUnited States, Canada
-
AllerganCompletedBacterial ConjunctivitisUnited States
-
AllerganCompletedAcne VulgarisUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular HypertensionUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganTerminatedRash | Non-small-Cell Lung CancerUnited States
-
AllerganCompleted
-
AllerganCompletedArthritis, Rheumatoid | Lupus Erythematosus, Systemic | Scleroderma, Systemic | Keratoconjunctivitis Sicca | Sjogren's SyndromeUnited States
-
AllerganCompletedOcular HypertensionUnited States
-
AllerganCompletedPosterior Uveitis | Intermediate UveitisFrance, United Kingdom, United States, Spain, Poland, India, South Africa, Korea, Republic of, Canada, Czech Republic, Australia, Germany, Israel, Switzerland, Portugal, Austria, Brazil, Greece
-
AllerganCompletedDry Eye SyndromeUnited States
-
AllerganCompletedStroke | Muscle SpasticityUnited States, Canada
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedOcular Hypertension | GlaucomaUnited States
-
AllerganCompletedFacial Rhytides | Skin Folds | Loss of Volume and Skin QualityBrazil
-
AllerganCompletedRefractory GlaucomaChina
-
AllerganCompletedTemple HollowingChina
-
AllerganCompletedPlatysma ProminenceUnited States, Canada
-
AllerganActive, not recruiting